Avita Medical Stock Current Asset
| RCEL Stock | USD 5.75 0.05 0.86% |
Fundamental analysis of Avita Medical allows traders to better anticipate movements in Avita Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Avita Medical Company Current Asset Analysis
Avita Medical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Avita Medical has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Avita Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avita Medical's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avita Medical could also be used in its relative valuation, which is a method of valuing Avita Medical by comparing valuation metrics of similar companies.Avita Medical is currently under evaluation in current asset category among its peers.
Avita Fundamentals
| Return On Equity | -4.07 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (0.64) % | ||||
| Current Valuation | 171.58 M | ||||
| Shares Outstanding | 26.43 M | ||||
| Shares Owned By Insiders | 0.82 % | ||||
| Shares Owned By Institutions | 26.77 % | ||||
| Number Of Shares Shorted | 5.71 M | ||||
| Price To Book | 11.77 X | ||||
| Price To Sales | 2.14 X | ||||
| Revenue | 64.25 M | ||||
| Gross Profit | 61.25 M | ||||
| EBITDA | (55.34 M) | ||||
| Net Income | (61.84 M) | ||||
| Cash And Equivalents | 84.17 M | ||||
| Cash Per Share | 0.67 X | ||||
| Total Debt | 45.98 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.64 X | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (48.94 M) | ||||
| Short Ratio | 18.88 X | ||||
| Earnings Per Share | (2.19) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 16.94 | ||||
| Number Of Employees | 260 | ||||
| Beta | 1.52 | ||||
| Market Capitalization | 153.32 M | ||||
| Total Asset | 79.71 M | ||||
| Retained Earnings | (359.81 M) | ||||
| Working Capital | 36.84 M | ||||
| Net Asset | 79.71 M |
About Avita Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avita Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avita Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avita Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Avita Medical Piotroski F Score and Avita Medical Altman Z Score analysis. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.